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Transcranial magnetic stimulation (TMS) is a non-
invasive technique used to stimulate the human brain
in vivo using very strong, pulsed magnetic fields.
Magnets exist in the natural world in a very weak form,
and technologic advances in the last 2 decades have
made it possible for magnetic stimulators to produce
sufficient electric current in the brain to cause neuronal
depolarization.
Repetitive TMS (rTMS) is rapidly developing
as a powerful, non-invasive tool for studying the
human brain,1 and also as a novel treatment for
neuropsychiatric disorders.2 The magnetic field
strength used clinically (about 2 T) is about 40,000
times the earth’s magnetic field. Clinically, rTMS has
been applied to treat mood and anxiety disorders,
schizophrenia, movement disorders, and epilepsy.
rTMS was first reported to have antidepressant efficacy
in 6 medication-resistant patients with depression.3
Subsequently, there were many open and controlled
studies of this novel therapy.
In a systematic review of data from 14 randomized
controlled trials in patients with depression who
received or did not receive rTMS, an effect in favor of
rTMS was evident: after 2 weeks’ treatment, the
standardized mean difference in Hamilton Rating
Scale for Depression (HAM-D) score between the
rTMS and control group was –0.35 (95% confidence
interval [CI] –0.66, –0.04); however, the standardized
mean difference at a 2-week follow-up visit was not
statistically significant (–0.33; 95% CI, –0.84, 0.17).4
The authors suggested that studies were of low quality
and provided insufficient evidence to support the use
of rTMS in the treatment of depression.4 Further,
in a randomized controlled comparison of electro-
convulsive therapy (ECT) with rTMS in severe
and resistant, nonpsychotic, major depression, the
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response rate was almost the same between the 2
groups.5 However, as rTMS is non-invasive and has
only few, mild, adverse effects compared with ECT, it
is highly acceptable to both patients and therapists.
In this issue of the journal, Huang et al6 report an
open trial of rTMS as add-on therapy to antidepressants
in 11 patients with medication-resistant depression.
This is the first rTMS study in psychiatric patients in
Taiwan. The patients, 3 males and 8 females (mean
age, 40.6 ( 11.7 years), received a 2-week regimen of
rTMS (100% of motor threshold; 5 Hz; 8 sec; 40
trains/20 mins/day; 10 weekdays) besides their original
antidepressant therapy. In 10 patients who completed
the trial, the response rate (50% reduction of HAM-D
score) was 50%, and 2 patients experienced complete
remission (HAM-D score ) 7). One patient withdrew
from the trial because of intolerable headache after
the third rTMS session. Mild headache immediately
after rTMS was frequently reported, but no other
adverse effects were reported. From this preliminary
study, the authors suggested that rTMS might improve
mood in Taiwanese patients with medication-resistant
depression.6
The mechanisms by which rTMS may treat
depression remain unclear. In animal studies, rTMS
was reported to induce ECT-like changes in rat brain
monoamines, ` -adrenergic receptor binding, and gene
induction.2 In humans, most results have come from
neuroimaging studies; indeed, TMS combined with
positron-emission tomography or functional magnetic
resonance imaging may permit precise elucidation
of changes in brain biochemistry and physiology.7
Importantly, as rTMS appears to be highly acceptable
to patients with depression, the acquisition of clinical
experience with this novel therapy is now warranted
here in Taiwan.
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